Skip to content

Public FDA record

Z-2000-2020: Central Venous Catheters are indicated for the assessment of hemodynamic status through right atrial, rig

Recall record Z-2000-2020 for ICU Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2000-2020
Company in FDA record
ICU Medical, Inc.
FDA record creation date
May 14, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Inability for the guidewire to pass through the needles included with the catheter kits.

Source facts

Action
The firm has contracted Stericycle, Inc., Indianapolis, IN for customer notification, response tracking and effectiveness check. On 02 January 2020, Stericycle, Inc. sent URGENT: MEDICAL DEVICE RECALL notification of the market action to the firm's direct consignees of record.
Initiated
2020-01-02
Root cause
Process control
Terminated
2022-09-14
Distribution
US Consignees including in the states of AL, CA, FL, GA, IL, ME, MI, MN, MS, NC, NH, NM, NY, OH, TX, UT, VA and WA OUS - Canada.
Recall number
Z-2000-2020
Recall status
Terminated
CDRH record ID
180689
FDA record created
2020-05-14
Recall event number
85361

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗